Albuterol manufacturers
Pro Research Analysisby 
Searched over 200M research papers for "albuterol manufacturers"
Albuterol Manufacturers and Product Variations
Albuterol, also known as salbutamol, is produced by several pharmaceutical companies in various formulations, including nebulizer solutions, metered-dose inhalers (MDIs), and dry-powder inhalers (DPIs). Major manufacturers include Glaxo (now part of GlaxoSmithKline), which produces Ventolin-branded albuterol products, and other companies such as Boehringer Ingelheim, Cardinal Health, Smith's Medical, WestMed, B&B Medical Technologies, and Teva Pharmaceuticals, which have developed both branded and generic versions of albuterol inhalers and nebulizer solutions 1267.
Albuterol Nebulizer Solutions: Key Manufacturers
Glaxo (GlaxoSmithKline) is a leading manufacturer of albuterol nebulizer solutions, offering products like Ventolin Respirator Solution and Ventolin Nebules PF. These are commonly used in clinical settings and are available in both preservative-containing and preservative-free forms . Other companies, such as Cardinal Health (AirLife Misty Finity), Smith's Medical (Flo-Mist), WestMed (Heart), and B&B Medical Technologies (Hope), manufacture large-volume nebulizers used for continuous albuterol delivery, with each brand having specific performance characteristics and manufacturer recommendations for use .
Albuterol Inhalers: Regulatory Changes and Manufacturer Impact
The U.S. Food and Drug Administration (FDA) mandated a transition from chlorofluorocarbon (CFC) propellants to hydrofluoroalkane (HFA) propellants in albuterol inhalers, which led to the discontinuation of generic CFC inhalers and left only branded HFA inhalers on the market for a period of time. This regulatory change benefited pharmaceutical companies producing HFA inhalers, such as GlaxoSmithKline and others, by allowing them to raise prices due to the lack of generic competition . The FDA has specific requirements for the approval of both innovator and generic albuterol inhalers, including chemistry, manufacturing, and controls (CMC) and bioequivalence testing, which manufacturers must meet to bring new or generic products to market .
Combination and Novel Albuterol Inhaler Products
Manufacturers have also developed combination inhalers, such as albuterol with ipratropium bromide (marketed as Combivent by Boehringer Ingelheim) and albuterol-budesonide combinations, which offer improved efficacy and convenience for patients with asthma or chronic obstructive pulmonary disease (COPD) 46. These combination products are subject to additional regulatory scrutiny to demonstrate that each component contributes to the overall efficacy .
New Albuterol Inhaler Technologies
Recent innovations include the introduction of dry-powder inhalers (DPIs) for albuterol, such as the RespiClick device, which is manufactured by Teva Pharmaceuticals. This device is designed to be easier to use than traditional MDIs, with features like breath-actuation and integrated dose counters, improving patient satisfaction and adherence .
Conclusion
Albuterol is manufactured by several major pharmaceutical companies, with GlaxoSmithKline, Boehringer Ingelheim, and Teva Pharmaceuticals among the most prominent. These companies produce a range of albuterol products, including nebulizer solutions, MDIs, DPIs, and combination inhalers. Regulatory changes and technological advancements have influenced the availability, pricing, and design of albuterol inhalers, with manufacturers adapting to meet both clinical needs and regulatory requirements 1234+3 MORE.
Sources and full results
Most relevant research papers on this topic